Zobrazeno 1 - 10
of 37
pro vyhledávání: '"F. Cogny van Weydevelt"'
Autor:
F Cogny Van Weydevelt, P N'Doye, Yvon Lebranchu, Guy Touchard, Olivier Toupance, P Peyronnet, T Hauet, B. Hurault de Ligny, Marc Busson
Publikováno v:
Nephrology Dialysis Transplantation. 12:1956-1960
There is considerable debate about whether maintenance cyclosporin (CsA) monotherapy is advisable or not in renal transplantation.Between August 1984 and December 1989, 463 adult patients received a first cadaver graft. Initial immunosuppression was
Autor:
P Jallet, A Minebois-Villegas, M. Audran, F Le Levier, F Boux de Casson-Raimbeau, A. Lortholary, P. Giraud, F Cogny-Van Weydevelt
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 8:287-291
Resume Nous presentons les resultats analytiques et cliniques d'un dosage du peptide analogue de l'hormone parathyroidienne : le PTHrp. Il s'agit d'un dosage RIA par competition de specificite N-terminale. Cette methode presente de bons criteres anal
Publikováno v:
Transplantation Proceedings. 29:32S-34S
Publikováno v:
Transplantation proceedings. 28(5)
Publikováno v:
Transplantation proceedings. 27(2)
Autor:
F, Cogny-Van Weydevelt, D, Chautard, Y, Bourree, C, Ngohou, K, Bacquaert-Dufour, R, Delva, P, Riberi
Publikováno v:
Transplantation proceedings. 27(2)
Publikováno v:
Transplantation Proceedings. 32:434-435
Publikováno v:
Thymus. 18(2)
Leukotriene B4 (LTB4) is produced by a large variety of cells involved in immune response and it has been demonstrated that this arachidonic acid metabolite acts as an immunomodulator. Because LTB4 and IL-2 both influence the physiology of immature c
Autor:
A. Chevailler, G. Renier, D. Hurez, J.F. Subra, F. Cogny van Weydevelt, P. Riberi, A. Bergelin
Publikováno v:
La Revue de Médecine Interne. 12:S323
We examined clinical, biological and anatomical findings of 256 patients who were tested for the presence of antineutrophil cytoplasmic antibodies (ANCA) during last 3 years in the immunopathology laboratory. We found 37 patients with positive ANCA:
Autor:
A. Goldstein, F. Babinet, P. Lebon, J.F. Subra, F. Cogny-Van-Weydevelt, E. Kernaonet, P. Riberi, P. Tirot
Publikováno v:
La Revue de Médecine Interne. 11:S336
Renal failure is often present in high tumoral mass multiple myeloma. We report a retrospective study of 16 consecutive patients presenting with stage III B myeloma treated with VAD or VAD-PECC as induction therapy. Median survival was 20 months. Thi